Founded in March 2024, Anondita Medicare Limited manufactures flavored male condoms, with its flagship product branded as “COBRA.” The company produces 562 million condoms annually.
The company has a manufacturing facility situated in Noida, Uttar Pradesh.
Anondita Medicare exports its products to several international markets, including Southeast Asia, Africa, and the Middle East.
The company collaborates with global health organizations, NGOs, and governments to support family planning and public health initiatives.
Anondita Medicare has a robust distribution network that ensures the timely delivery of its products to various markets.
The company collaborates with wholesalers, retailers, and e-commerce platforms to make its products widely accessible. It also has strong ties with government health programs and institutions, playing a key role in supplying essential medical products for public health initiatives.
As on July 31, 2025, the Company had 280 employees.
Competitive Strength:
| Investory Category | Subscription Percentage | Amount Raised (₹ Crores) |
|---|---|---|
| Qualified Institutional Buyers (QIBs) | 50% | 17,21,500 crores |
| Non-Institutional Investors (NIIs) | 15% | 5,16,450 crores |
| Retail Individual Investors (RIIs) | 35% | 12,05,050 crores |
| Allotment Date | Listing Date | Refund Date |
|---|---|---|
| 28 Aug '25 | 01 Sep '25 | 29 Aug '25 |
| Issue Composition: | |
|---|---|
| Face Value | ₹0 per share |
| Total Issue Size | 34,43,000 shares (aggregating up to ₹2,90,000 crores) |
| Fresh Issue | NaN shares (aggregating up to To be announced) |
| Offer for Sale | NaN shares of ₹0 (aggregating up to To be announced) |
| Issue Type | |
| Post-Issue Shareholding Pattern: | |
|---|---|
| Pre-Issue Shareholding | shares |
| Post-Issue Shareholding | 0 shares |
| Minimum Lot Size | -- |
| Maximum Lot Size (Retail) | -- |
The lot size of Anondita Medicare ipo has been designed to ensure broad participation while maintaining optimal price discovery.
| Book Running Lead Manager(s) |
|---|